FRC
FRC Logo
Community
Sign InGet Access

Connect With Us

Stay updated with our latest research and insights

Fundamental Research Corp Logo

Highly ranked equity research firm providing institutional grade tools and analysis to all investors worldwide. Trusted by global investors for over 20+ years.

20+ Years
Rate us on TrustpilotLeave a review

Policies

  • Privacy Policy
  • Terms of Service
  • Disclaimer

Company

  • About Us
  • Our Team
  • Contact Us
  • Leave a Review

Resources

  • Videos
  • Research Reports
  • Community
  • FAQ
  • How to use the site

Browse

  • Stock Directory
  • Stock Screener
  • Market Intel Weekly
  • Report Archive

Trackers

  • Congress Trading
  • Senate Trading
  • Congress Net Worth
  • Markets

© 2026 Fundamental Research Corp. All Rights Reserved.

Professional investment research since 2003

Home
Strategies
Intel
Analysis
Community
Company ProfileAdherium Limited
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
ADR.AX
Adherium Limited Stock AnalysisComprehensive stock analysis for Adherium Limited (ADR.AX) including live price, Snowflake performance metrics, financial statements, and investment research.Stock AnalysisADR.AX
ADR.AX
Adherium Limited
  • Company Overview
  • Financial Data
  • Peer Comparison
  • Ownership & News
  • Discussion
ADR.AX
  1. Home
  2. Stocks
  3. Adherium Limited

Adherium Limited

🇦🇺ADR.AX•ASX

Adherium Limited

🇦🇺ADR.AX•ASX

Your view on ADR.AX

Your view
Company Overview

Overview

What the company does, where it operates, and who runs it.

About Adherium Limited

Industry
Medical - Devices
Sector
Healthcare
CEO
Dawn Bitz
Headquarters
447 Collins Street, Melbourne, VIC, AU
Industry
Medical - Devices
Sector
Healthcare
CEO
Dawn Bitz
Headquarters
447 Collins Street, Melbourne, VIC, AU
Description

Adherium Limited specializes in developing, manufacturing, and providing advanced digital health solutions. The company's core mission is to enhance medication adherence for individuals managing chronic conditions in key international markets, spanning New Zealand, Australia, Europe, North America, and Asia.

A central offering is Hailie, a comprehensive system engineered to optimize medication use for patients suffering from chronic respiratory illnesses like asthma and chronic obstructive pulmonary disease (COPD).

This innovative solution integrates Bluetooth-enabled Hailie sensors, which discreetly attach to patients' inhalers to deliver immediate feedback. The Hailie ecosystem is further supported by an intuitive mobile application and a dedicated online portal. Established in 2001, Adherium Limited is headquartered in Auckland, New Zealand.

Financial Data

Stock Data

Price chart, volume, and trading data.

Financial Ratios

Profitability, returns, valuation, and leverage ratios.

About this section

Valuation, profitability, liquidity and leverage ratios for Adherium Limited. Starting points for Adherium Limited: EPS -AUD 0.26, beta 1.05 — an Medical - Devices name. P/E, P/B, EV/EBITDA, margins, return on equity, current ratio and debt coverage, each shown against the company's own history.

Dividend Analysis

Yield, payout ratio, and dividend coverage metrics.

About this section

Dividend history, yield and payout sustainability for Adherium Limited. Adherium Limited does not currently pay a regular dividend, so this section tracks capacity rather than history. Per-share payments, yield over time, payout ratio and growth streak, with coverage measured against free cash flow.

Earnings Analysis

EPS history, beat rate, and upcoming earnings reports.

About this section

Reported vs. expected earnings history for Adherium Limited. Trailing twelve-month EPS for Adherium Limited stands at -AUD 0.26. EPS surprises by quarter, revenue against estimates, and the upcoming reporting date.

Wall Street Analyst Estimates

Analysts' price targets, ratings, and revenue and EPS estimates.

Third partyAs of Nov 20, 2026 · AUD

Price targets, ratings and estimates published by outside analysts. Not FRC research, not a recommendation, and not the FRC Fair Value: that is FRC's proprietary model, built on the cash a company generates.

Earnings Estimate

EPSCurrent QtrJun 2017Next QtrJun 2018Current YearFY Jun 2027Next YearFY Jun 2028
Avg. estimate−AUD 0.06−AUD 0.05−AUD 8.02AUD 5.34
Low estimate−AUD 0.07−AUD 0.05−AUD 8.02AUD 5.34
High estimate−AUD 0.06−AUD 0.05−AUD 8.02AUD 5.34
No. of analysts3211
Year-ago EPS——−AUD 0.001—
Growth————

1Year-ago EPS includes one-time items; growth not shown.

Revenue Estimate

RevenueCurrent QtrJun 2017Next QtrJun 2018Current YearFY Jun 2027Next YearFY Jun 2028
Avg. estimateAUD 4.80MAUD 8.71MAUD 7.42MAUD 31.57M
Low estimateAUD 3.65MAUD 8.33MAUD 7.42MAUD 31.57M
High estimateAUD 5.81MAUD 8.75MAUD 7.42MAUD 31.57M
No. of analysts3211
Year-ago revenue——AUD 2.10M—
Growth——+253.4%—

Source: Wall Street analysts' published price targets, ratings and estimates, compiled by Financial Modeling Prep; as of Nov 20, 2026. Not FRC research or a recommendation.

Financial Statements

Income statement, balance sheet, and cash flow statements.

About this section

Income statement, balance sheet and cash flow history for Adherium Limited. Adherium Limited has reported as a listed company since 2015. Annual and quarterly filings with period-over-period comparison, so you can trace how revenue, margins and cash generation have moved.

Peer Comparison

Comparables

List of peer companies in the same industry.

Peers, the industry, and the funds that hold ADR.AX19 companies
Compare ADR.AX with its peers, side by sidePremiumRatios, margins, valuation and leverage of the peers below — one table, one glance.Open Comparable Analysis
Peer companies
TickerTypeCompanySectorIndustry
BGT.AXBio-Gene Technology LimitedBasic MaterialsAgricultural Inputs—
CAN.AXCann Group LimitedHealthcareDrug Manufacturers - Specialty & Generic—
HIQ.AXHITIQ LimitedHealthcareMedical - Healthcare Information Services—
ICR.AXIntelicare Holdings LimitedHealthcareMedical - Healthcare Information Services—
IVX.AXInvion LimitedHealthcareDrug Manufacturers - Specialty & Generic—
IXC.AXInvex Therapeutics LtdHealthcareBiotechnology—
PER.AXPercheron Therapeutics LimitedHealthcareDrug Manufacturers - Specialty & Generic—
More Medical - Devices companies
TickerTypeCompanySectorExchangeMkt cap
CBLLCeriBell, Inc.HealthcareNASDAQ$995.3M
CERSCerus CorporationHealthcareNASDAQ$391.8M
CGHCCapital Group Holdings, Inc.HealthcareOTC$9,220
CHEOFCochlear LimitedHealthcareOTC$8.9B
CHEOYCochlear LimitedHealthcareOTC$9.2B
CHYPFHealth Logic Interactive Inc.HealthcareOTC$165,839
CLLKFBICO Group AB (publ)HealthcareOTC$123.3M
CLPTClearPoint Neuro, Inc.HealthcareNASDAQ$247.1M
CLVSFCellaVision AB (publ)HealthcareOTC$378.0M
CMP.AXCompumedics LimitedHealthcareASX—
CNMDCONMED CorporationHealthcareNYSE$1.4B
CNVIFConavi Medical Corp.HealthcareOTC$20.7M
Open Comparable Analysis
Ownership & News

News

Latest headlines and market coverage.

About this section

Latest headlines and company announcements for Adherium Limited. Coverage tracks Adherium Limited within Medical - Devices (Healthcare). Press releases and market coverage, newest first.

Discussion

Comments

Comments and replies from FRC members about this company.

No comments yet

Be the first to ask a question or say what you make of Adherium Limited.

ADR.AX AnalysisWeak
Past
1
Growth
1
Health
1
Profit
1
Value
1

News

Latest Market News